Harnessing the Power of Technology: MOMBA for Postpartum Smoking
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
2 other identifiers
interventional
26
1 country
1
Brief Summary
Through a smartphone platform, financial incentives for smoking abstinence in postpartum women can be delivered remotely, thus minimizing the need for participants to come to the office to receive traditional contingency management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Feb 2017
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2014
CompletedFirst Posted
Study publicly available on registry
September 11, 2014
CompletedStudy Start
First participant enrolled
February 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2019
CompletedResults Posted
Study results publicly available
May 21, 2020
CompletedMay 21, 2020
May 1, 2020
2.3 years
September 9, 2014
March 10, 2020
May 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Acceptability
Primary Outcome - Acceptability of the delivery of financial incentives for smoking abstinence in postpartum women through a smartphone platform as compared to traditional, in office contingency management. Acceptability of the smartphone application to low-income, pregnant women defined by the percentage of women who would recommend the site to a friend. Question: "How likely is it that you would recommend MoMba LiveLong to a friend who wants to stop smoking?"
3 and 9 months
Enrollment Rate
Primary Outcome - Feasibility of the delivery of financial incentives for smoking abstinence in postpartum women through a smartphone platform as compared to traditional, in office contingency management. Feasibility: participation rate of \> 60% for eligible women between screening and enrollment. Number of women who were eligible from screening that completed an intake.
15 months
Remote Detection
Primary outcome is the correlation coefficient. The correlation coefficient was calculated between the piCO+™ and the Sensordrone™ specific to expired CO measurement and verified through urine cotinine levels. Data for all three instruments was collected during week 1 visits 1-5, 3 month, 9 month and 15 month assessments.
15 months
Retention: Number of Participants Remaining in Study at 12 Weeks
Primary Outcome - Feasibility of the delivery of financial incentives for smoking abstinence in postpartum women through a smartphone platform as compared to traditional, in office contingency management. Feasibility: retention set at 80% for the Momba Smoking group. Number of participants in the intervention group (MoMba Contingency Management) and number of participants in the control group (office contingency management) who remained in the study at the end of contingency management (12 weeks).
15 months
Visit Attendance / Challenge Completion
Primary Outcome - Feasibility of the delivery of financial incentives for smoking abstinence in postpartum women through a smartphone platform as compared to traditional, in office contingency management. Feasibility: challenge completion and in-office visit attendance to assess compliance. MoMba Contingency Management: Number of breath tests completed among participants who remained enrolled at the end of 12 weeks. Office Contingency Management: Number of breath tests (corresponds to office visits) completed among participants who remained enrolled at the end of 12 weeks.
15 months
Secondary Outcomes (3)
Number of Participants With Short Term Abstinence From Smoking
3 months
Number of Participants With Long Term Abstinence From Smoking at 9 Month Follow-Up
9 months
Number of Participants With Long Term Abstinence From Smoking at 15 Month Follow-Up
15 months
Study Arms (2)
MoMba Contingency Management
EXPERIMENTALStudy will provide access to the web-based MoMba Live Long application \& Sensodrone™ carbon-monoxide sensor for purposes of researching the acceptability of the smartphone application, operating and functioning of it, and providing remote contingency management for smoking cessation to postpartum women.
Office contingency management
ACTIVE COMPARATORTraditional contingency management with financial incentives delivered in-person in the office for smoking cessation to postpartum women
Interventions
MoMba Live Long application \& Sensordrone™ carbon-monoxide sensor to deliver contingency management remotely
A control group which will receive financial incentives at an in-person office/clinic visit based on expired CO levels obtained through the piCO sensor.
A custom breath CO meter built by Sensorcon Inc. (Sensordrone, part No. SDRONEG1) that uses an electrochemical CO gas sensor to measure environmental CO. The Sensordrone is accurate to within 10% with a resolution of 1 parts per million (ppm). The Sensordrone pairs via Bluetooth with the MoMba Live Long application.
The MoMba Live Long app provides an interface for the Sensordrone which allows participants to complete a breath test and see results of smoking status. The app verifies the user is correctly taking the tests by recording pictures using the front facing camera as well as recording audio to verify that the participants where exhaling while taking the test. The app also provided a platform for social interaction based on a previous system where app users can interact with each other and provide support during the quitting process.
Eligibility Criteria
You may qualify if:
- Women who are over the age of 18
- Speak English
- Second or third trimester of pregnancy
- Smoking in the third trimester of pregnancy
- No complicating general medical or psychiatric conditions (including marijuana use).
You may not qualify if:
- Receiving other smoking cessation medication
- Planning to move out of New Haven in the next 15 months
- Actively suicidal, psychotic or unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Center for Wellbeing of Women and Mothers, 40 Temple Street, Ste 6B, Yale University
New Haven, Connecticut, 06510, United States
Related Publications (1)
Valencia S, Callinan L, Shic F, Smith M. Evaluation of the MoMba Live Long Remote Smoking Detection System During and After Pregnancy: Development and Usability Study. JMIR Mhealth Uhealth. 2020 Nov 24;8(11):e18809. doi: 10.2196/18809.
PMID: 33231550DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Megan Smith
- Organization
- Yale School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Megan V Smith, DrPH
Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2014
First Posted
September 11, 2014
Study Start
February 10, 2017
Primary Completion
May 13, 2019
Study Completion
May 13, 2019
Last Updated
May 21, 2020
Results First Posted
May 21, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share